BIO-CHEM(603360)
Search documents
大连百傲化学股份有限公司 2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-29 21:29
Core Viewpoint - The company, Dalian Baiao Chemical Co., Ltd., has released its third-quarter financial report for 2025, highlighting significant changes in product prices and raw material costs, which may impact its financial performance moving forward [3][10]. Financial Data Summary - The third-quarter financial report is unaudited, and the company assures the accuracy and completeness of the information provided [3][8]. - The average selling price of the company's products decreased by 7.59% quarter-on-quarter and 23.62% year-on-year [8]. - The comprehensive procurement cost of major raw materials, including n-octanol, methyl acrylate, magnesium nitrate, ethyl acetate, and chlorine, decreased by 23.12% quarter-on-quarter and 29.29% year-on-year [9]. Shareholder Information - The company has a total of 5,365,500 shares held in a repurchase account, representing 0.76% of the total share capital [6]. Other Significant Matters - No other significant matters affecting the company's production and operations were reported during the quarter [10].
百傲化学(603360.SH)发布前三季度业绩,归母净利润1.25亿元,同比下降50.83%
智通财经网· 2025-10-29 14:58
Core Insights - Baiao Chemical (603360.SH) reported a revenue of 1.056 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 17.88% [1] - The company's net profit attributable to shareholders decreased by 50.83% to 125 million yuan [1] - The non-recurring net profit also saw a decline of 52.13%, amounting to 117 million yuan [1] - Basic earnings per share stood at 0.18 yuan [1]
百傲化学(603360.SH):前三季度净利润1.25亿元,同比下降50.83%
Ge Long Hui A P P· 2025-10-29 09:34
Core Viewpoint - Baiao Chemical (603360.SH) reported a total operating revenue of 1.056 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 17.88%. However, the net profit attributable to shareholders decreased by 50.83% to 125 million yuan, with basic earnings per share at 0.18 yuan [1]. Financial Performance - Total operating revenue for the first three quarters reached 1.056 billion yuan, showing a year-on-year increase of 17.88% [1] - Net profit attributable to shareholders was 125 million yuan, reflecting a significant decline of 50.83% compared to the previous year [1] - Basic earnings per share stood at 0.18 yuan [1]
百傲化学(603360) - 2025 Q3 - 季度财报
2025-10-29 08:20
Financial Performance - Q3 2025 revenue was CNY 307.19 million, a decrease of 1.77% year-over-year, while year-to-date revenue reached CNY 1.06 billion, an increase of 17.88%[2] - Total profit for Q3 2025 was CNY 38.08 million, down 61.89% year-over-year, and year-to-date profit totaled CNY 152.91 million, a decrease of 46.67%[2] - Net profit attributable to shareholders for Q3 2025 was CNY 33.21 million, a decline of 62.97% year-over-year, with year-to-date net profit at CNY 125.00 million, down 50.83%[2] - Basic earnings per share for Q3 2025 were CNY 0.05, a decrease of 61.54% year-over-year, while year-to-date earnings per share were CNY 0.18, down 50.00%[2] - Net profit for the first three quarters of 2025 was ¥135,722,003.40, a decrease of 46.6% from ¥254,222,021.32 in the same period of 2024[18] - The company reported a total comprehensive income of ¥135,817,733.24 for the first three quarters of 2025, compared to ¥248,258,469.13 in the previous year, a decrease of 45.4%[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3.66 billion, an increase of 0.44% compared to the end of the previous year[3] - The company's total assets amounted to ¥3,655,758,357.15, slightly up from ¥3,639,769,869.79 in the previous year[14] - Total liabilities increased to ¥1,577,454,878.85, compared to ¥1,288,572,546.59 in the same period last year, marking a rise of 22.4%[14] - The company's equity attributable to shareholders decreased to ¥1,506,239,379.42 from ¥1,788,474,436.44, a decline of 15.7%[14] Shareholder Information - Shareholders' equity attributable to the parent company was CNY 1.51 billion, a decrease of 15.78% from the end of the previous year[3] - Total number of common shareholders at the end of the reporting period is 23,953[9] - The largest shareholder, Dalian Tongyun Investment Co., Ltd., holds 211,581,520 shares, accounting for 29.96% of total shares[9] - The second largest shareholder, Dalian Guangyao Zhixin Shuhong Enterprise Management Consulting Partnership, holds 182,411,659 shares, representing 25.83%[9] - The company has a total of 14,341,976 shares held by Dalian Sanxin Investment Co., Ltd., representing 2.03% of total shares[9] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 195.69 million, a decrease of 17.02% compared to the previous year[2] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $1.06 billion, a significant increase from $739.16 million in the same period of 2024, representing a growth of about 43.6%[21] - Net cash flow from operating activities decreased to $195.69 million in 2025 from $235.84 million in 2024, reflecting a decline of approximately 17%[22] - Total cash inflow from investment activities was $141.52 million in 2025, compared to $127.62 million in 2024, marking an increase of about 10.9%[22] - Net cash flow from investment activities worsened to -$288.47 million in 2025 from -$147.50 million in 2024, indicating a decline in investment performance[22] - Cash inflow from financing activities surged to $1.02 billion in 2025, up from $273.92 million in 2024, representing an increase of approximately 272%[22] - Net cash flow from financing activities improved to $70.06 million in 2025, compared to a negative $150.50 million in 2024, showing a positive turnaround[22] - The company's cash and cash equivalents at the end of Q3 2025 stood at $646.25 million, an increase from $418.18 million at the end of Q3 2024[22] - The total cash outflow from operating activities increased to $867.03 million in 2025 from $503.33 million in 2024, reflecting a rise of approximately 72.3%[22] Operational Costs and Expenses - The significant decline in profits was attributed to increased operating costs and reduced investment income, despite revenue growth in the semiconductor business segment[7] - Total operating costs for the first three quarters of 2025 were ¥911,498,010.69, up 49.4% from ¥610,218,244.99 in the previous year[16] - Research and development expenses increased to ¥54,120,901.18 in the first three quarters of 2025, compared to ¥36,394,316.27 in 2024, reflecting a growth of 48.5%[18] Stock and Share Structure - The company implemented a stock dividend distribution in May 2025, increasing total shares from 504,445,467 to 706,223,654[3] - The company has a total of 5,365,500 shares held in the repurchase special securities account, which accounts for 0.76% of the total share capital[10] - The company has no significant changes in the shareholding structure or related party transactions during the reporting period[11] Accounting and Reporting - The company did not apply new accounting standards for the year 2025, maintaining consistency in financial reporting[23]
百傲化学:第三季度归母净利润3320.81万元,同比下降62.97%
Xin Lang Cai Jing· 2025-10-29 08:17
Core Viewpoint - The company reported a decline in net profit for Q3 2025, indicating potential challenges in maintaining profitability despite revenue growth in the first three quarters of the year [1] Financial Performance - In Q3 2025, the company achieved an operating income of 307 million yuan, a year-on-year decrease of 1.77% [1] - The net profit attributable to shareholders for Q3 2025 was 33.21 million yuan, down 62.97% year-on-year [1] - Basic earnings per share for Q3 2025 were 0.05 yuan [1] - For the first three quarters of 2025, the company reported an operating income of 1.056 billion yuan, reflecting a year-on-year growth of 17.88% [1] - The net profit attributable to shareholders for the first three quarters was 125 million yuan, a decline of 50.83% year-on-year [1] - Basic earnings per share for the first three quarters were 0.18 yuan [1]
百傲化学(603360) - 大连百傲化学股份有限公司关于2025年第三季度主要经营数据的公告
2025-10-29 08:16
关于 2025 年第三季度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号——行业信息披露第十 三号——化工》等规定的要求,大连百傲化学股份有限公司(以下简称"公司") 将 2025 年第三季度主要经营数据披露如下: 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2025 | 年第三季度 | 2025 年第三季度 | | 2025 年第三季度 | | --- | --- | --- | --- | --- | --- | | | | 产量(吨) | 销量(吨) | | 销售收入(万元) | | 工业杀菌剂 | | 12,194.85 | | 9,725.31 | 20,110.18 | 证券代码:603360 证券简称:百傲化学 公告编号:2025-077 大连百傲化学股份有限公司 1、主要产品的价格变化情况 公司 2025 年第三季度产品平均销售价格环比下降 7.59%,同比下降 23.62%。 2、主要原材料的价格变化情况 公司 2025 年 ...
农化制品板块10月21日涨1.12%,蓝丰生化领涨,主力资金净流出1.21亿元
Zheng Xing Xing Ye Ri Bao· 2025-10-21 08:21
Core Viewpoint - The agricultural chemical sector experienced a 1.12% increase on October 21, with Lanfeng Biochemical leading the gains. The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1]. Sector Performance - The agricultural chemical sector saw individual stock performances as follows: - Lanfeng Biochemical (002513) closed at 8.86, up 10.06% with a trading volume of 1.0553 million shares and a transaction value of 875 million yuan - Dongfang Tower (002545) closed at 14.59, up 4.66% with a trading volume of 182,400 shares and a transaction value of 262 million yuan - Yajing International (000893) closed at 41.05, up 3.82% with a trading volume of 73,500 shares and a transaction value of 300 million yuan - Other notable performances include Green Heng Technology (920866) up 3.37%, Chitianhua (600227) up 2.88%, and Jinzhen Da (002470) up 2.84% [1]. Capital Flow - The agricultural chemical sector experienced a net outflow of 121 million yuan from institutional investors, while retail investors saw a net inflow of 136 million yuan. Speculative funds had a net outflow of 14.34 million yuan [1].
大连百傲化学股份有限公司关于2023年员工持股计划第二个锁定期届满暨解锁条件成就的公告
Shang Hai Zheng Quan Bao· 2025-10-20 20:05
Core Viewpoint - The announcement details the completion of the second lock-up period for the 2023 employee stock ownership plan of Dalian Baiao Chemical Co., Ltd, allowing 83 participants to unlock a total of 5,075,932 shares, which represents 0.72% of the company's total share capital [1][8][9]. Summary of Relevant Sections Employee Stock Ownership Plan Approval and Implementation - The employee stock ownership plan was approved through a series of meetings held on August 28, September 13, and October 19, 2023, with independent directors expressing their agreement [2][3][4]. - The plan involved the transfer of 5,179,522 unrestricted shares to the employee stock ownership plan account on October 13, 2023 [4]. Lock-up Period and Unlocking Conditions - The second lock-up period for the employee stock ownership plan ended on October 16, 2025, after a 24-month period following the transfer of shares [6][7]. - The board confirmed that the performance assessment conditions for unlocking the shares were met, allowing 83 participants to unlock the shares, with adjustments made for one participant's poor performance and two departures [8][9]. Legal and Compliance Opinions - The legal opinion confirmed that the unlocking of shares complied with relevant regulations and that the necessary approvals were obtained [10]. - The management committee is authorized to distribute cash or transfer unlocked shares to participants' personal accounts as per the plan's provisions [10].
百傲化学(603360) - 大连百傲化学股份有限公司关于2023年员工持股计划第二个锁定期届满暨解锁条件成就的公告
2025-10-20 09:15
证券代码:603360 证券简称:百傲化学 公告编号:2025-076 大连百傲化学股份有限公司 关于 2023 年员工持股计划第二个锁定期届满 暨解锁条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 大连百傲化学股份有限公司(以下简称"公司")于 2025 年 10 月 20 日召 开第五届董事会第十五次会议,审议通过《关于 2023 年员工持股计划第二个锁 定期届满暨解锁条件成就的议案》,根据《大连百傲化学股份有限公司 2023 年 员工持股计划》(以下简称"《员工持股计划》"或"本员工持股计划")、《大 连百傲化学股份有限公司 2023 年员工持股计划管理办法》(以下简称"《管理 办法》")的有关规定,公司 2023 年员工持股计划第二个锁定期解锁条件已成 就,83 名持有人在第二个解锁期可解锁股票数量为 5,075,932 股(调整后), 现将有关事项说明如下: 一、2023 年员工持股计划批准及实施情况 (一)本员工持股计划履行的审议程序 1、2023 年 8 月 28 日,公司召开第四届董事会第十九次 ...
百傲化学(603360) - 北京德恒律师事务所关于大连百傲化学股份有限公司2023年员工持股计划第二个锁定期届满暨解锁条件成就的法律意见
2025-10-20 09:15
北京德恒律师事务所 关于大连百傲化学股份有限公司 2023 年员工持股计划第二个锁定期届满 暨解锁条件成就的 法律意见 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 北京德恒律师事务所 关于大连百傲化学股份有限公司 2023 年员工持股计划 第二个锁定期届满暨解锁条件成就的法律意见 北京德恒律师事务所 关于大连百傲化学股份有限公司 2023 年员工持股计划第二个锁定期届满 暨解锁条件成就的 法律意见 德恒 01G20250064-3 号 致:大连百傲化学股份有限公司 北京德恒律师事务所(以下简称"本所")受大连百傲化学股份有限公司(以 下简称"百傲化学"或"公司")委托,根据《中华人民共和国公司法》(以下 简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、 《中国证券监督管理委员会关于上市公司实施员工持股计划试点的指导意见》 (以下简称"《指导意见》")、《上海证券交易所上市公司自律监管指引第 1 号——规范运作》(以下简称"《规范运作指引》")等有关法律、法规及规范 性文件以及《大连百傲化学 ...